Akin Advises Pharmakon in $250 Million Senior Secured Term Loan to Zenas BioPharma
Contact:
(New York) – Akin advised Pharmakon Advisors, LP, an investment management firm specializing in providing strategic financing solutions to the life sciences industry, and the BioPharma Credit Investment funds, in connection with a $250 million senior secured term loan to Zenas BioPharma, Inc., a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases.
The Akin team was led by tax partner Geoffrey Secol and included fellow tax partner Stuart Leblang and associate John Kwack; international trade partner Nnedinma Ifudu Nweke; health care & life sciences partner Nate Brown, senior counsel Jo-Ellyn Klein, counsel Emily Gerry and associates Jenna Becker and Maddy Bolger; and corporate associates Jake Gawlak and Yossi Abadi.
Akin is a leading international law firm with more than 1,000 lawyers in offices throughout the United States, Europe, Asia and the Middle East.
# # #
People Mentioned in This News
